Technical University Clinic Munich
Welcome,         Profile    Billing    Logout  
 8 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Combs, Stephanie E
INTRAGO-II, NCT02685605: Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme

Active, not recruiting
3
314
Europe, Canada, US, RoW
Standard surgery, Intraoperative radiotherapy, IORT, Radiochemotherapy, Temozolomide
Universitätsmedizin Mannheim, Carl Zeiss Meditec AG, University of California, Los Angeles
Glioblastoma
06/24
06/26
NANORAY-312, NCT04892173 / 2021-002163-22: NBTXR3 With or Without Cetuximab in LA-HNSCC

Recruiting
3
500
Europe, Canada, Japan, US, RoW
NBTXR3, Functionalized hafnium oxide nanoparticles, Cetuximab, Erbitux, Radiation Therapy
Nanobiotix, Nanobiotix SA
Locally Advanced Head and Neck Squamous Cell Carcinoma, Aged
06/26
06/27
Escalox, NCT01212354 / 2010-021139-15: Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT

Recruiting
3
270
Europe
Radiotherapy, IMRT-SIB
Technische Universität München
Locally Advanced Head and Neck Cancer
01/25
09/25
SATURNUS, NCT05160818: Hypofractionated Versus Single Fraction Stereotactic Adjuvant Radiotherapy to the Resection Cavity of Brain Metastases

Recruiting
3
126
Europe
Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiotherapy radiosurgery (SRS)
Technische Universität München
Brain Metastases, Resection Cavity
08/25
08/25
NCT04246684: Short RT Versus RCT,Followed by Chemo.and Organ Preservation for Interm and High-risk Rectal Cancer Patients

Active, not recruiting
3
702
Europe
Oxaliplatin, 85 mg/m2, Control arm, 5FU; 2400 mg/m2, 5-FU, control arm, 5FU, 250 mg/m2, Experimental arm: 5-FU, 5FU, 2400 mg/m2, experimental arm, Oxaliplatin 50 mg/m2, Experimental arm, Folinic Acid, 400 mg/m2, Folinic Acid, Radiotherapy control, 5x5 Gy: 25 Gy, Capecitabine, 1000 mg/m2, Capecitabine, Oxaliplatin 85 mg/m2, radiotherapy experimental, 30 x 1,8 Gy: 54 Gy, Capecitabine, 825 mg/m2, Oxaliplatin, 130 mg/m2, Oxaliplatin
Prof. Dr. med. Claus Rödel
Rectal Cancer Stage III
09/23
09/28
GlioCave/NOA17, NCT02715297: Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma

Recruiting
2
162
Europe
SRT to the resection cavity
Technische Universität München, Helmholtz Zentrum München
Glioblastoma
02/23
02/23
RADIANCE, NCT04230759 / 2018-003005-25: Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. a Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group

Active, not recruiting
2
180
Europe
Chemotherapy, all brands of 5-fluorouracil (5-FU) are allowed, all brands of Mitomycin C (MMC) are allowed, Radiation, Durvalumab, PD-L1 inhibitor
Goethe University, German Cancer Aid, AstraZeneca
Anal Cancer, Anal Carcinoma, Anal Cancer Stage III, Anal Cancer Stage II
12/26
03/27
ESPADURVA, NCT04202809 / 2019-000058-77: Phase-II Trial of Induction Chemotherapy and Chemoradiotherapy Plus/Minus Durvalumab and Consolidation Immunotherapy in Patients With Resectable Stage III NSCLC.

Recruiting
2
90
Europe
Durvalumab
University Hospital, Essen, Astra Zeneca
NSCLC, Stage III
04/25
04/25
PersoMed-I, NCT04402073 / 2020-003063-26: Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma

Active, not recruiting
2
20
Europe, RoW
Sonidegib, Cisplatin, Lomustine, Vincristine, radiotherapy
European Organisation for Research and Treatment of Cancer - EORTC, EORTC-BTG, Sunpharmaceuticals
Medulloblastoma
04/25
04/25
DELPHI, NCT03396718: De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas

Recruiting
1
304
Europe
De-escalation radio(chemo)therapy - Level 1, De-escalation radio(chemo)therapy - Level 2, Standard radio(chemotherapy)
Technische Universität Dresden, German Cancer Research Center, National Center for Tumor Diseases (NCT) Dresden, National Center for Tumor Diseases, Heidelberg, Radiation Oncology Working Group of the German Cancer Society
Head-and-neck Squamous Cell Carcinoma
11/29
11/32
ProtoChoice-P, NCT02766686: Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With Protons

Recruiting
N/A
146
Europe
Radiotherapy with protons, Radiotherapy with photons
Technische Universität Dresden, German Consortium for Translational Cancer Research, National Center for Radiation Research in Oncology Dresden/Heidelberg, Radiation Oncology Working Group of the German Cancer Society
Prostate Cancer
02/24
02/26
B-REST, NCT05975190: Respiratory Training and Relaxation Techniques to Improve Adjuvant Radiation Therapy in DIBH in Breast Cancer

Recruiting
N/A
108
Europe
Respiratory training and relaxation techniques under adjuvant radiation therapy in DIBH in breast cancer
Technical University of Munich, German Cancer Aid
Radiotherapy, Breast Cancer, Relaxation, Breathholding
07/25
12/25

Download Options